Uterine cancers: Clinical practice guidelines in oncology™

Benjamin E. Greer*, Wui Jin Koh, Nadeem Abu-Rustum, Michael A. Bookman, Robert E. Bristow, Susana Campos, Kathleen R. Cho, Larry Copeland, Patricia Eifel, Wainwright Jaggernauth, Anuja Jhingran, Daniel S. Kapp, John Kavanagh, Gary H. Lipscomb, John R. Lurain, Robert J. Morgan, Subir Nag, Edward E. Partridge, C. Bethan Powell, Steven W. RemmengaR. Kevin Reynolds, William Small, John Soper, Nelson Teng

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations


Adenocarcinoma of the endometrium is the most common malignancy of the female genital tract in the United States. Many physicians believe that adenocarcinoma of the endometrium is a relatively benign disease because of the early symptoms of irregular vaginal bleeding in this predominantly postmenopausal patient population, the often-localized nature of the disease, and the generally high survival rate. However, the estimated number of deaths from endometrial cancer continues to increase, indicating the need for a critical reassessment of the guidelines for managing endometrial cancer. Physicians must identify high-risk patients and tailor treatment appropriately to provide the best opportunity for long-term survival.

Original languageEnglish (US)
Pages (from-to)438-462
Number of pages25
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number5
StatePublished - May 2006


  • Chemotherapy
  • Endometrial carcinoma
  • Hysterectomy
  • NCCN Clinical Practice Guidelines
  • Radiation therapy
  • Staging
  • Surgery
  • Uterine cancer
  • Uterine sarcomas

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Uterine cancers: Clinical practice guidelines in oncology™'. Together they form a unique fingerprint.

Cite this